Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GALA-5: 5-ALA and Gliadel Wafers in Glioblastoma
NCT01310868Phase 2Completed
- Sponsor
- University College London
- Start
- May 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid, carmustine in glioblastoma (GBM), sponsored by University College London. Started May 2011; status: completed.
02
Drugs
5-aminolevulinic acidcarmustine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01310868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310868.